A detailed history of T. Rowe Price Investment Management, Inc. transactions in Erasca, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 16,830,856 shares of ERAS stock, worth $41.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,830,856
Previous 7,374,359 128.23%
Holding current value
$41.7 Million
Previous $17.4 Million 164.01%
% of portfolio
0.03%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.17 - $3.28 $20.5 Million - $31 Million
9,456,497 Added 128.23%
16,830,856 $45.9 Million
Q2 2024

Aug 14, 2024

BUY
$1.79 - $2.63 $13.2 Million - $19.4 Million
7,374,359 New
7,374,359 $17.4 Million

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $303M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.